Diagnostic Potential of the Plasma Lipidome in Infectious Disease: Application to Acute SARS-CoV-2 Infection

Improved methods are required for investigating the systemic metabolic effects of SARS-CoV-2 infection and patient stratification for precision treatment. We aimed to develop an effective method using lipid profiles for discriminating between SARS-CoV-2 infection, healthy controls, and non-SARS-CoV-2 respiratory infections. Targeted liquid chromatography–mass spectrometry lipid profiling was performed on discovery (20 SARS-CoV-2-positive; 37 healthy controls; 22 COVID-19 symptoms but SARS-CoV-2negative) and validation (312 SARS-CoV-2-positive; 100 healthy controls) cohorts. Orthogonal projection to latent structure-discriminant analysis (OPLS-DA) and Kruskal–Wallis tests were applied to establish discriminant lipids, significance, and effect size, followed by logistic regression to evaluate classification performance. OPLS-DA reported separation of SARS-CoV-2 infection from healthy controls in the discovery cohort, with an area under the curve (AUC) of 1.000. A refined panel of discriminant features consisted of six lipids from different subclasses (PE, PC, LPC, HCER, CER, and DCER). Logistic regression in the discovery cohort returned a training ROC AUC of 1.000 (sensitivity = 1.000, specificity = 1.000) and a test ROC AUC of 1.000. The validation cohort produced a training ROC AUC of 0.977 (sensitivity = 0.855, specificity = 0.948) and a test ROC AUC of 0.978 (sensitivity = 0.948, specificity = 0.922). The lipid panel was also able to differentiate SARS-CoV-2-positive individuals from SARS-CoV-2-negative individuals with COVID-19-like symptoms (specificity = 0.818). Lipid profiling and multivariate modelling revealed a signature offering mechanistic insights into SARS-CoV-2, with strong predictive power, and the potential to facilitate effective diagnosis and clinical management.

[1]  Lanjuan Li,et al.  Alterations in the human oral and gut microbiomes and lipidomics in COVID-19 , 2021, Gut.

[2]  J. Nicholson,et al.  Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses , 2021, Journal of proteome research.

[3]  Chunbo Chen,et al.  Lipidomic alteration of plasma in cured COVID-19 patients using ultra high-performance liquid chromatography with high-resolution mass spectrometry , 2021, Bioscience reports.

[4]  G. Fabbrocini,et al.  Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19 , 2021, Scientific Reports.

[5]  P. Pelosi,et al.  Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies , 2021, Frontiers in Physiology.

[6]  M. Spraul,et al.  NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines. , 2021, Journal of proteome research.

[7]  Q. Lu,et al.  COVID-19 and autoimmune diseases , 2020, Current opinion in rheumatology.

[8]  G. Cappellano,et al.  Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2 , 2020, International journal of molecular sciences.

[9]  Dain R. Brademan,et al.  Large-Scale Multi-omic Analysis of COVID-19 Severity , 2020, Cell Systems.

[10]  Kenneth G. C. Smith,et al.  Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection , 2020, Journal of proteome research.

[11]  Shelly C. Lu,et al.  SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum , 2020, iScience.

[12]  Gek Huey Chua,et al.  Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis , 2020, Cell Metabolism.

[13]  E. Hod,et al.  COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. , 2020, JCI insight.

[14]  L. Plantier,et al.  The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism , 2020, Scientific Reports.

[15]  L. Kucirka,et al.  Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure , 2020, Annals of Internal Medicine.

[16]  Hong Wang,et al.  Plasma metabolomic and lipidomic alterations associated with COVID-19 , 2020, medRxiv.

[17]  E. Herker,et al.  Whole Lotta Lipids—From HCV RNA Replication to the Mature Viral Particle , 2020, International journal of molecular sciences.

[18]  Michael J MacCoss,et al.  Skyline for Small Molecules: A Unifying Software Package for Quantitative Metabolomics. , 2020, Journal of proteome research.

[19]  G. Gkoutos,et al.  Machine learning for the detection of early immunological markers as predictors of multi-organ dysfunction , 2019, Scientific Data.

[20]  O. Fiehn,et al.  Inborn Errors of Metabolism in the Era of Untargeted Metabolomics and Lipidomics , 2019, Metabolites.

[21]  Sanjiv J. Shah,et al.  Elevated Plasma Ceramides Are Associated With Antiretroviral Therapy Use and Progression of Carotid Artery Atherosclerosis in HIV Infection , 2019, Circulation.

[22]  D. L. Mascarenhas,et al.  Lipidomic Analysis Reveals Serum Alteration of Plasmalogens in Patients Infected With ZIKA Virus , 2019, Front. Microbiol..

[23]  Kristin E. Burnum-Johnson,et al.  Plasma lipidome reveals critical illness and recovery from human Ebola virus disease , 2019, Proceedings of the National Academy of Sciences.

[24]  J. Chan,et al.  Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication , 2019, Viruses.

[25]  L. Moreno,et al.  Ceramide and Regulation of Vascular Tone , 2019, International journal of molecular sciences.

[26]  C. Hellerbrand Inhibition of monoacylglycerol lipase for the treatment of liver disease: tempting but still playing with fire , 2018, Gut.

[27]  S. Summers,et al.  The ceramide ratio: a predictor of cardiometabolic risk1 , 2018, Journal of Lipid Research.

[28]  Xia Zhao,et al.  High-resolution lipidomics reveals dysregulation of lipid metabolism in respiratory syncytial virus pneumonia mice , 2018, RSC advances.

[29]  T. Standiford,et al.  Associations of the plasma lipidome with mortality in the acute respiratory distress syndrome: a longitudinal cohort study , 2018, Respiratory Research.

[30]  K. Lauber,et al.  Elevated Serum Lysophosphatidylcholine in Patients with Systemic Lupus Erythematosus Impairs Phagocytosis of Necrotic Cells In Vitro , 2018, Front. Immunol..

[31]  C. Barbas,et al.  Metabolomic-Based Methods in Diagnosis and Monitoring Infection Progression , 2018, Experientia supplementum.

[32]  Georg Heinze,et al.  Variable selection – A review and recommendations for the practicing statistician , 2018, Biometrical journal. Biometrische Zeitschrift.

[33]  Kristin E. Burnum-Johnson,et al.  Multi-platform 'Omics Analysis of Human Ebola Virus Disease Pathogenesis. , 2017, Cell host & microbe.

[34]  Y. Li,et al.  Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection , 2017, Scientific Reports.

[35]  N. Mehta,et al.  Lipid Abnormalities and Inflammation in HIV Inflection , 2016, Current HIV/AIDS Reports.

[36]  Young-Mo Kim,et al.  Integrated Omics Analysis of Pathogenic Host Responses during Pandemic H1N1 Influenza Virus Infection: The Crucial Role of Lipid Metabolism. , 2016, Cell host & microbe.

[37]  J. Souza-Neto,et al.  A Lipidomics Approach in the Characterization of Zika-Infected Mosquito Cells: Potential Targets for Breaking the Transmission Cycle , 2016, PloS one.

[38]  Xiaofeng Yang,et al.  Lysophospholipids and their G protein-coupled receptors in atherosclerosis. , 2016, Frontiers in bioscience.

[39]  Adam D. Kennedy,et al.  Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism , 2015, Journal of Inherited Metabolic Disease.

[40]  T. Pritts,et al.  Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis , 2015, Journal of Molecular Medicine.

[41]  Melinda M. Mulvihill,et al.  Therapeutic potential of monoacylglycerol lipase inhibitors. , 2013, Life sciences.

[42]  D. Cheillan,et al.  Amino acid profiling for the diagnosis of inborn errors of metabolism. , 2011, Methods in molecular biology.

[43]  F. Negro Abnormalities of lipid metabolism in hepatitis C virus infection , 2010, Gut.

[44]  E. Gulbins,et al.  Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis. , 2010, American journal of respiratory cell and molecular biology.

[45]  B. Hurley,et al.  Multiple Roles of Phospholipase A2 during Lung Infection and Inflammation , 2008, Infection and Immunity.

[46]  John D. Storey The positive false discovery rate: a Bayesian interpretation and the q-value , 2003 .

[47]  G. Schmitz,et al.  Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients Published, JLR Papers in Press, January 16, 2003. DOI 10.1194/jlr.M200401-JLR200 , 2003, Journal of Lipid Research.

[48]  L. di Marzio,et al.  Ceramide concentrations in septic patients: a possible marker of multiple organ dysfunction syndrome. , 1999, Critical care medicine.

[49]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .